Foreign trade, imports and exports of SHIRE PERU S.A.C.
RUC: 20602177441
PERU | Imports and exports

On VERITRADE you will find imports and exports of SHIRE PERU S.A.C., Foreign trade information: prices, products, customers, competition, suppliers and more.
FOREIGN TRADE IN THE LAST 5 YEARS:
SHIRE PERU S.A.C.
IMPORTS
- - Records:
- 35
- - US$:
- 13,602,120
EXPORTS
- Does not record records.
It does not register exports in this period
Top Imported Products
Products | Reg. | US$ | ||
---|---|---|---|---|
LOS DEMAS MEDICAMENTOS PARA USO HUMANO | 16 | 6,668,682 | 123 % |
For more information request a free trial
Top Origin Countries
Countries | Reg. | US$ | ||
---|---|---|---|---|
AUSTRIA | 7 | 5,654,130 | 104 % | |
UNITED STATES | 9 | 1,014,552 | 19 % |
For more information request a free trial
Shipping Details
With Veritrade you can see the details of the operations at the maximum level allowed by each country, resulting in the following.

1 |
12/24/2019
|
3004902900 | 217 | 217 | KG | 4,433.54 | 223508-1 | SWITZERLAND | FEIBA 500U FEIBA S/M COMPLEJO COAGULANTE ANTI INHIBIDOR INYECTABLE. ELABORADO POR BAXTER AG.- AUSTRIA PRODUCTO PARA LA INDUSTRIA FARMACEUTICA, POLVO PARA SOLUCION INYECTABLE FEIBA, 500U MATERIAL No. 1503573 - LOTE: F2U046AJ F.EXP. 31/07/2021 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
2 |
11/27/2019
|
3004902900 | 3 | 3 | KG | 73,982.23 | 205069-1 | IRELAND | ELAPRASE 2MG/ML 3.0ML PE ELAPRASE S/M EXPEDIENTE DE REINSCRIPCION N° 18050087, SUCE 2018258349 FECHA 30/05/2018 ELABORADO POR CANGENE BIOPHARMA, INC - ESTADOS UNIDOS DE AMERICA ELAPRASE 2MG/ML 3.0ML PE, PRINCIPIO ACTIVO: IDURSULFASA MATERIAL: 5000042 - LOTE: 19B0185 - DATE MANUFACTURE: 07/03/2019 - EXPIRY DATE: 02/2022 | ||
3 |
10/7/2019
|
3004902900 | 0 | 0 | KG | 83,001.33 | 171594-1 | IRELAND | ELAPRASE 2MG/ML 3.0ML PE ELAPRASE S/M EXPEDIENTE DE REINSCRIPCION N° 18050087, SUCE 2018258349 FECHA 30/05/2018 ELABORADO POR CANGENE BIOPHARMA, INC - ESTADOS UNIDOS DE AMERICA ELAPRASE 2MG/ML 3.0ML PE, PRINCIPIO ACTIVO: IDURSULFASA MATERIAL: 5000042, LOTE: 19B0141, DATE MANUFACTURE: 07/03/2019, EXPIRY DATE: 28/02/2022 | ||
4 |
10/7/2019
|
3004902900 | 1 | 1 | KG | 83,001.30 | 171594-2 | IRELAND | ELAPRASE 2MG/ML 3.0ML PE ELAPRASE S/M EXPEDIENTE DE REINSCRIPCION N° 18050087, SUCE 2018258349 FECHA 30/05/2018 ELABORADO POR CANGENE BIOPHARMA, INC - ESTADOS UNIDOS DE AMERICA ELAPRASE 2MG/ML 3.0ML PE, PRINCIPIO ACTIVO: IDURSULFASA MATERIAL: 5000042, LOTE: 19B0185, DATE MANUFACTURE: 07/03/2019, EXPIRY DATE: 28/02/2022 | ||
5 |
9/18/2019
|
3004902900 | 62 | 62 | KG | 4,386.59 | 160308-1 | SWITZERLAND | FEIBA 500U FEIBA S/M COMPLEJO COAGULANTE ANTI INHIBIDOR INYECTABLE. ELABORADO POR BAXTER AG.- AUSTRIA PRODUCTO PARA LA INDUSTRIA FARMACEUTICA, POLVO PARA SOLUCION INYECTABLE FEIBA, 500U MATERIAL No. 1503573, LOTE: F2U035BAF, F/V: 31/05/2021 | ||
6 |
7/4/2019
|
3004902900 | 1 | 1 | KG | 85,522.44 | 113944-1 | IRELAND | ELAPRASE 2MG/ML 3.0ML PE ELAPRASE S/M EXPEDIENTE 18-050087-1 POR REINSCRIPCION DE REGISTRO SANITARIO ELABORADO POR CANGENE BIOPHARMA, INC - ESTADOS UNIDOS DE AMERICA ELAPRASE 2MG/ML 3.0ML PE, PRINCIPIO ACTIVO: IDURSULFASA MATERIAL: 5000042, LOTE: 19B0033, F/V: 30.09.2021 | ||
7 |
8/22/2019
|
3004902900 | 167 | 167 | KG | 4,536.08 | 144356-1 | SWITZERLAND | FEIBA 500U FEIBA S/M FEIBA 500U PRODUCTO PARA LA INDUSTRIA FARMACEUTICA, POLVO PARA SOLUCION INYECTABLE ELABORADO POR BAXTER AG.- AUSTRIA.. COMPLEJO COAGULANTE ANTI INHIBIDOR INYECTABLE MATERIAL No. 1503573 LOTE : F2U017AN VCTO 28-02-2021 | ||
8 |
7/24/2019
|
3004902900 | 9 | 9 | KG | 6,550.07 | 126924-1 | IRELAND | ELAPRASE 2MG/ML 3.0ML PE ELAPRASE S/M SOLUCION INYECTABLE PARA INFUSION / CAJA DE CARTON X 1,4Y 10 VIALES DE VIDRIO TIPO I ELABORADO POR CANGENE BIOPHARMA, INC - ESTADOS UNIDOS DE AMERICA ELAPRASE 2MG/ML 3.0ML PE, MATERIAL: 5000042, LOTE: 19B0141, F/V: 28.02.22 |
For more information request a free trial